Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chief Legal Officer

Chief Executive Officer

General Counsel and Secretary

Chief  Executive Officer

Chief Medical Officer

Viridian Therapeutics, Inc., a biotechnology company, discover and develops treatments for serious and rare diseases. The company's product pipeline includes VRDN-001, a monoclonal antibody targeting insulin-like growth factor-1 receptor that is in Phase 3 clinical trial for the treatment of thyroid eye disease (TED); and VRDN-002 and VRDN-003, a next generation IGF-1R humanized monoclonal antibodies targeting IGF-1R and incorporating half-life extension technology for the treatment of TED. It also provides VRDN-004, a discovery-stage therapeutic antibody program for rare disease; and VRDN-005 and VRDN-006, a preclinical program for autoimmune disease. The company was formerly known as Miragen Therapeutics, Inc. and changed its name to Viridian Therapeutics, Inc. in January 2021. Viridian Therapeutics, Inc. is headquartered in Waltham, Massachusetts.

Viridian Therapeutics, Inc., a biotechnology company, discover and develops treatments for serious and rare diseases.

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-03-28	Premium	sold	Premium	Premium	Premium	-
2024-03-28	Premium	acquired	Premium	Premium	Premium	-
2024-01-22	Premium	bought	Premium	Premium	Premium	-
2023-06-16	Premium	acquired	Premium	Premium	Premium	Chief Legal Officer
2023-06-16	Premium	sold	Premium	Premium	Premium	Chief Legal Officer
2023-06-15	Premium	sold	Premium	Premium	Premium	Chief Legal Officer
2023-06-15	Premium	acquired	Premium	Premium	Premium	Chief Legal Officer
2023-06-06	Premium	acquired	Premium	Premium	Premium	Chief Legal Officer
2023-06-06	Premium	sold	Premium	Premium	Premium	Chief Legal Officer
2023-06-05	Premium	sold	Premium	Premium	Premium	Chief Legal Officer
2023-06-05	Premium	acquired	Premium	Premium	Premium	Chief Legal Officer
2023-06-02	Premium	acquired	Premium	Premium	Premium	Chief Legal Officer
2023-06-02	Premium	sold	Premium	Premium	Premium	Chief Legal Officer
2023-04-12	Premium	bought	Premium	Premium	Premium	Chief Executive Officer
2023-03-13	Premium	bought	Premium	Premium	Premium	Chief Executive Officer
2023-03-09	Premium	sold	Premium	Premium	Premium	General Counsel and Secretary
2023-02-06	Premium	acquired	Premium	Premium	Premium	Chief Executive Officer
2023-02-02	Premium	sold	Premium	Premium	Premium	Chief Executive Officer
2023-02-02	Premium	acquired	Premium	Premium	Premium	Chief Executive Officer
2023-01-23	Premium	sold	Premium	Premium	Premium	General Counsel and Secretary
2023-01-23	Premium	acquired	Premium	Premium	Premium	General Counsel and Secretary
2023-01-17	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2023-01-17	Premium	sold	Premium	Premium	Premium	Chief Medical Officer
2023-01-13	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer

VRDN - Viridian Therapeutics, Inc. Stock Price, Fair Value and News

Latest Insider Trading transactions for VRDN